A survey of French Gynecologist knowledge and attitudes toward fertility preservation (FP) in young patients with endometrial cancer (EC) or endometrial atypical hyperplasia (AH)

被引：0
|
作者：
Peigne, M. [1 ]
Maumy, L. [1 ]
Koskas, M. [1 ]
机构：
[1] Bichat Claude Bernard Hosp, AP HP, Dept Gynecol Obstet & Reprod Med, Paris, France
来源：
HUMAN REPRODUCTION | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-451
引用
收藏
页码：349 / 349
页数：1
相关论文
共 50 条
  • [41] Fertility-sparing treatment outcomes for endometrial cancer and atypical hyperplasia patients with molecular subtypes beyond NSMP
    Wang, Yiqin
    Wang, Jianliu
    Bo, Linlin
    Kang, Nan
    Liu, Yuanyuan
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A169 - A171
  • [42] Exploring the impact of fertility-preserving treatment on pregnancy: key issues in patients with endometrial cancer and atypical hyperplasia
    Tang, Wei-Zhen
    Liu, Tai-Hang
    HUMAN REPRODUCTION, 2024, 39 (10) : 2364 - 2365
  • [43] METFORMIN MAY ATTENUATE THE EFFECT OF HYPERPROLACTINEMIA INDUCED BY MEDROXYPROGESTERONE ACETATE DURING FERTILITY-SPARING TREATMENT FOR PATIENTS WITH ATYPICAL ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL CANCER
    Mitsuhashi, A.
    Gu, W.
    Habu, U.
    Kobayashi, T.
    Shozu, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A346 - A346
  • [44] Fertility-sparing re-treatment for endometrial cancer and atypical endometrial hyperplasia patients with progestin-resistance: a retrospective analysis of 61 cases
    Chen, Junyu
    Cao, Dongyan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [45] Fertility-Sparing Treatment for Young Women with Atypical Hyperplasia and Early Endometrial Cancer with High-Dose Medrocyprogesterone Acetate
    Kyrgiou, Maria
    Pugh, Rebecca
    Hird, Vicky
    Smith, Richard
    Ghaem-Maghami, Sadaf
    Ghaem-Maghami, Alan
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 208A - 208A
  • [46] Efficacy of combinedmetformin and progestin therapy for complex atypical hyperplasia and well-differentiated endometrial cancer in patients desiring fertility
    Acosta-Torres, S.
    Doglioli, M.
    Varghese, A.
    Tanner, E. J., III
    Stone, R. L.
    Levinson, K. L.
    Beavis, A. L.
    Fader, A. N.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 267 - 267
  • [47] The results of different fertility-sparing treatment modalities and obstetric outcomes in patients with early endometrial cancer and atypical endometrial hyperplasia: Case series of 30 patients and systematic review
    Piatek, Szymon
    Michalski, Wojciech
    Sobiczewski, Piotr
    Bidzinski, Mariusz
    Szewczyk, Grzegorz
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2021, 263 : 139 - 147
  • [48] GnRH-a based fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients: a multicenter, open-label, randomized designed clinical trial
    Liu, Qian
    Cao, Dongyan
    Zhou, Huimei
    Yu, Mei
    Yang, Jiaxin
    Wang, Tao
    Wang, Yongxue
    Wang, Jinhui
    Peng, Peng
    Cheng, Ninghai
    Shen, Keng
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A18 - A18
  • [49] Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
    Yamagami, Wataru
    Susumu, Nobuyuki
    Makabe, Takeshi
    Sakai, Kensuke
    Nomura, Hiroyuki
    Kataoka, Fumio
    Hirasawa, Akira
    Banno, Kouji
    Aoki, Daisuke
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2018, 29 (02)
  • [50] Effect and Management of Excess Weight in the Context of Fertility-Sparing Treatments in Patients With Atypical Endometrial Hyperplasia and Endometrial Cancer: Eight-Year Experience of 227 Cases
    Shan, Ying
    Qin, Meng
    Yin, Jie
    Cai, Yan
    Li, Yan
    Gu, Yu
    Wang, Wei
    Wang, Yong-xue
    Chen, Jia-yu
    Jin, Ying
    Pan, Ling-ya
    FRONTIERS IN ONCOLOGY, 2021, 11
12345